USCOM LIMITED — Board/Management Information 2010

Jan 31, 2010

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

New Global Marketing and Distribution Appointment

Monday 1st February, 2010: Uscom (ASX code: UCM) today announced the appointment of Ms Debra Johnson to the position of Vice President of Global Marketing and Distribution. Debra Is based in Seattle and will be responsible for co-ordinating and optimising Uscom global sales channels and resources.

Debra Johnson has a clinical background and has been employed by Spacelabs Healthcare in sales and marketing roles for the last 13 yrs, most recently as Director of Strategic Alliances. Debra is US based with a close understanding of the sales organisation of Spacelabs Healthcare, Uscom’s in hospital strategic marketing partner, and will be responsible for management of sales channels across Nth America, Central and Sth America, Europe, the Middle East and Asia Pacific. Debra will report directly to the CEO.

Mr Rob Phillips, the Uscom Executive Chairman and acting CEO, said “Debra brings a wealth of experience in device sales and marketing to Uscom at a time when our sales channels have been set in place and are poised for rapid growth. This US appointment represents the next step in the beefing up of the Uscom sales organisation and is an expansionary investment as Uscom grows to become a global Medical Device Company. Knowing Uscom and Spacelabs Healthcare as well as Debra does will allow seamless continuity and rapid traction in this new management role.”

About Uscom

Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India and Australia by Spacelabs Healthcare, while in China and SE Asia USCOM is distributed by Pacific Medical Systems and in New Zealand it is distributed by MedXus.

Uscom Contacts Rob Phillips Chief Executive Officer rob@uscom.com.au

Daniel Fah Company Secretary daniel.fah@uscom.com.au